Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • My watchlists
  • Help
  • Contact us

Integrated Diagnostics Holdings Plc (IDHC) ORD USD0.25

Sell:$1.23 Buy:$1.29 0 Change: $0.01 (0.81%)
Market closed |  Prices as at close on 22 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$1.23
Buy:$1.29
Change: $0.01 (0.81%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 22 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$1.23
Buy:$1.29
Change: $0.01 (0.81%)
Market closed |  Prices as at close on 22 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Integrated Diagnostics Holdings plc is an integrated diagnostics services provider in Egypt. The Company operates in three geographic areas: Egypt, Sudan and Jordan. The Company provides over 1,000 diagnostic services ranging from basic tests to molecular tests for hepatitis and specialized deoxyribonucleic acid (DNA) tests to patients, and operates approximately 310 branches. The Company offers a range of services, such as Immunology, Radiology, Hematology, Endocrinology, Molecular Biology, Cytogenetics, Hatopathology and Microbiology. The Company's core brands include Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan, and Ultralab and Al Mokhtabar Sudan in Sudan. The Company also operates the Medical Genetics Centre brand in Egypt. Its Al Mokhtabar medical testing and diagnostic center provides services, including radiological tests, a center for allergy, a unit for nutritional advice, pre-employments tests, medical examination in different fields and checkup packages.

Contact details

Address:
12 Castle Street
SAINT HELIER
JE2 3RT
Jersey
Telephone:
+44 (01534) 847000
Website:
www.idhcorp.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 02 September 2021 02/09/21
Final dividend payment date 29 July 2021 29/07/21
Final ex-dividend date 08 July 2021 08/07/21
AGM 30 June 2021 30/06/21
Annual report 07 June 2021 07/06/21
Quarterly results 02 June 2021 02/06/21
Final results 19 May 2021 19/05/21
Trading Announcement 18 February 2021 18/02/21
EGM 23 December 2020 23/12/20
Quarter 3 results 19 November 2020 19/11/20
Interim dividend payment date 02 October 2020 02/10/20

General stock information

EPIC:
IDHC
ISIN:
JE00BLKGSR75
Market cap:
$732.00 million
Shares in issue:
600.00 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
US dollar
Indices:
n/a

Key personnel

  • Hend El Sherbini
    Group Chief Executive Officer, Executive Director
  • Omar Bedewy
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.